<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T06:19:01Z</responseDate>
  <request identifier="oai:figshare.com:article/34018850" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34018850</identifier>
        <datestamp>2026-09-29T01:05:53Z</datestamp>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Conditional
Mutant MAPT Overexpression
in Neural Organoids Elicits Robust Tau Accumulation and Pathological
Transcriptomic Responses</dc:title>
          <dc:creator>Andrew Kjar (21252584)</dc:creator>
          <dc:creator>Hyosung Kim (3079212)</dc:creator>
          <dc:creator>Madeline R. Spetz (19774488)</dc:creator>
          <dc:creator>Zev Jarrett (25133639)</dc:creator>
          <dc:creator>Melanie Fernandez (25133642)</dc:creator>
          <dc:creator>Jaime Wang (25133645)</dc:creator>
          <dc:creator>Maria L. Russotti (25133648)</dc:creator>
          <dc:creator>Caroline Bodnya (10291730)</dc:creator>
          <dc:creator>Daniel Chavarria (1641433)</dc:creator>
          <dc:creator>Timothy J. Hohman (8356254)</dc:creator>
          <dc:creator>Vivian Gama (10291742)</dc:creator>
          <dc:creator>Brad Grueter (25133651)</dc:creator>
          <dc:creator>Jonathan M. Brunger (13841415)</dc:creator>
          <dc:creator>Ethan S. Lippmann (1915207)</dc:creator>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>via doxycycline treatment</dc:subject>
          <dc:subject>neural organoids presents</dc:subject>
          <dc:subject>neural organoid systems</dc:subject>
          <dc:subject>measured transcriptomic responses</dc:subject>
          <dc:subject>lines containing disease</dc:subject>
          <dc:subject>concept framework showing</dc:subject>
          <dc:subject>inducible expression cassettes</dc:subject>
          <dc:subject>associated protein tau</dc:subject>
          <dc:subject>mapt &lt;/ italic</dc:subject>
          <dc:subject>mapt &lt;/</dc:subject>
          <dc:subject>phosphorylated tau</dc:subject>
          <dc:subject>inducible mutant</dc:subject>
          <dc:subject>taken together</dc:subject>
          <dc:subject>relevant alleles</dc:subject>
          <dc:subject>potential complement</dc:subject>
          <dc:subject>pathological events</dc:subject>
          <dc:subject>neurodegenerative phenotypes</dc:subject>
          <dc:subject>like regions</dc:subject>
          <dc:subject>like pathology</dc:subject>
          <dc:subject>generally relied</dc:subject>
          <dc:subject>cortical plate</dc:subject>
          <dc:description>Modeling neurodegenerative conditions in neural organoids
presents
a potential complement to existing preclinical translation pipelines.
Prior neural organoid models have generally relied on human induced
pluripotent stem cell (iPSC) lines containing disease-relevant alleles.
However, this strategy limits temporal control over the initiation
and progression of pathological events. In this study, we provide
a proof-of-concept framework showing that neurodegenerative phenotypes
can be triggered by inducible expression cassettes. We developed an
iPSC line harboring doxycycline-inducible mutant &lt;i&gt;MAPT&lt;/i&gt;, which encodes the microtubule-associated protein tau that is implicated
in tauopathies. Induction of mutant &lt;i&gt;MAPT&lt;/i&gt; via doxycycline
treatment in differentiating neural organoids yielded accumulation
of phosphorylated tau, which localized inside individual neuron somas
within the cortical plate-like regions. Importantly, measured transcriptomic
responses to tau overexpression bore key similarities to human clinical
transcriptomic data. Taken together, we present an approach for controlling
the initiation and progression of proteinopathy-like pathology in
neural organoid systems.</dc:description>
          <dc:date>2026-09-28T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acschemneuro.6c00376.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Conditional_Mutant_MAPT_Overexpression_in_Neural_Organoids_Elicits_Robust_Tau_Accumulation_and_Pathological_Transcriptomic_Responses/34018850</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
